1. Home
  2. SNEX vs PTCT Comparison

SNEX vs PTCT Comparison

Compare SNEX & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneX Group Inc.

SNEX

StoneX Group Inc.

HOLD

Current Price

$77.76

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$66.66

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNEX
PTCT
Founded
1924
1998
Country
United States
United States
Employees
5400
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.5B
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
SNEX
PTCT
Price
$77.76
$66.66
Analyst Decision
Strong Buy
Buy
Analyst Count
2
16
Target Price
$81.33
$80.94
AVG Volume (30 Days)
512.3K
959.7K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
264.48
EPS
2.50
7.78
Revenue
$132,378,200,000.00
$264,734,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.69
$19.30
P/E Ratio
$31.11
$8.61
Revenue Growth
32.53
36.19
52 Week Low
$65.58
$35.95
52 Week High
$132.57
$87.50

Technical Indicators

Market Signals
Indicator
SNEX
PTCT
Relative Strength Index (RSI) 27.64 47.92
Support Level N/A $61.43
Resistance Level $97.49 $69.29
Average True Range (ATR) 3.83 2.35
MACD -3.43 0.38
Stochastic Oscillator 21.15 50.28

Price Performance

Historical Comparison
SNEX
PTCT

About SNEX StoneX Group Inc.

StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: